Detection of HMGI-C in the peripheral blood of breast cancer patients

European Journal of Cancer

Volumn 36, Issue 15, 2000, Pages 1944-1948

  Sezer, O ^a   Langelotz, C ^a   Blohmer, J U ^a   Schmid, P ^a   Akrivakis, K ^a   Possinger, K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Breast cancer; High mobility group protein gene (HMGI C); Prognosis

Indexed keywords

HIGH MOBILITY GROUP PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033805315     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00199-4     Document Type: Article

References (20)

1. M. Bustin R. Reeves High-mobility-group chromosomal proteins architectural components that facilitate chromatin function Prog. Nucl. Acid Res. Mol. Biol. 54 1996 35 100
2. G. Tallini P. Dal Cin HMGI(Y) and HMGI-C dysregulation a common occurrence in human tumors Adv. Anat. Pathol. 6 1999 237 246
3. K. Chau P. Arlotta U.A. Patel C. Crane-Robinson G. Manfioletti S.J. Ono A novel downstream positive regulatory element mediating transcription of the human high mobility group protein (HMGI-C) gene FEBS Lett. 457 1999 429 436
4. G. Goodwin Molecules in focus — the high mobility group protein HMGI-C Int. J. Biochem. Cell. Biol. 30 1998 761 766
5. F. Mantovani S. Covaceuszach A. Rustighi NF-kappaB-mediated activation is enhanced by the architectural factor HMGI-C Nucl. Acids Res. 26 1998 1433 1439
6. P. Rogalla K. Drechsler G. Frey HMGI-C expression patterns in human tissues — implications for the genesis of frequent mesenchymal tumors Am. J. Pathol. 149 1996 775 779
7. X. Zhou K.F. Benson H.R. Ashar K. Chada Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C Nature 376 1995 771 774
8. B. Kazmierczak J. Bullerdiek K.H. Pham S. Bartnitzke H. Wiesner Intron 3 of HMGI-C is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years Cancer Genet. Cytogenet. 103 1998 175 177
9. M.T. Berlingieri G. Manfioletti M. Santoro Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells Mol. Cell. Biol. 15 1995 1545 1553
10. P. Rogalla K. Drechsler B. Kazmierczak V. Rippe U. Bonk J. Bullerdiek Expression of HMGI-C, a member of the high mobility group family, in a subset of breast cancers relationship to histologic grade Mol. Carcinogenesis 19 1997 153 156
11. P. Rogalla K. Drechsler W. Schröder-Babo K. Eberhardt J. Bullerdiek HMGI-C expression patterns in non-small lung cancer and surrounding tissue Anticancer Res. 18 1998 3327 3330
12. B. Rommel P. Rogalla A. Jox HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells Leukemia Lymphoma 26 1997 603 607
13. G. Chiappetta A. Bandiera M.T. Berlingieri The expression of the high mobility group HMGI(Y) proteins correlates with the malignant phenotype of human thyroid neoplasias Oncogene 10 1995 1307 1314
14. B. Staats U. Bonk S. Wanschura A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family Breast Cancer Res. Treat. 38 1996 299 303
15. B. Kazmierczak J. Rosigkeit S. Wanschura HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas a survey of 30 tumors Oncogene 12 1996 515 521
16. M. Klotzbucher A. Wasserfall U. Fuhrmann Misexpression of wild-type and truncated isoforms of the high mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas Am. J. Pathol. 155 1999 1535 1542
17. U.A. Patel A. Bandiera G. Manfioletti V. Giancotti K.Y. Chau C. Crane-Robinson Expression and cDNA cloning of human HMGI-C phosphoprotein Biochem. Biophys. Res. Commun. 201 1994 63 70
18. J.F.R. Robertson A.R. Dixon R.I. Nicholson C.W. Elston R.W. Blamey Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy Breast Cancer Res. Treat. 22 1992 221 227
19. N. Abe T. Watanabe M. Sugiyama Determination of high mobility group I (Y) expression levels in colorectal neoplasias a potential diagnostic marker Cancer Res. 59 1999 1169 1174
20. Y. Tamimi H.G. van der Poel H.F.M. Karthaus F.M. Debruyne J.A. Schalken A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization Br. J. Cancer 74 1996 573 578